Siguldas Ciltslietu Un Maksligas Apseklosanas Stacija (SCM1R) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
13 Jun, 2025Executive summary
Net sales for the nine months ended 30 September 2024 reached €1,193,264, up from €1,121,191 year-over-year.
Net profit for the period was €84,391, compared to €116,258 in the same period last year.
Earnings per share (EPS) stood at €0.200, down from €0.275 year-over-year.
Financial highlights
Operating income before tax was €84,431, a decrease from €116,314 year-over-year.
Cash and cash equivalents at period end were €127,726, up from €118,766 at the end of the previous period.
Shareholders' equity increased to €1,895,206 from €1,831,937 at year-end 2023.
Dividends of €21,122 were distributed during the period.
Outlook and guidance
Financial information was prepared using consistent accounting principles as previous reports.
The report is unaudited and management asserts it provides a true and fair view of the company's financial position.
Latest events from Siguldas Ciltslietu Un Maksligas Apseklosanas Stacija
- Net sales, profit, and EPS rose year-over-year, with improved equity and cash flow.SCM1R
Q3 202520 Nov 2025 - Net turnover grew 24.5% year-over-year, but profit before tax fell 6% to €57.7k.SCM1R
Q2 202521 Aug 2025 - Net turnover up 1% to €768.3k, but profit before tax down 27.6% to €61.4k.SCM1R
Q2 202413 Jun 2025 - 2024 net profit rose 23.5% to €80.8k, driven by genetics sales growth and stable operations.SCM1R
Q4 20249 Jun 2025 - Net sales up 24% and net profit increased, but operating cash flow turned negative.SCM1R
Q1 20256 Jun 2025